Total Funding
91
68
Total FundingPost-IPO Equity raised
Growth Score
-2 pts
Heat Score
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
51592
Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.
- Lawrence Steinman: Founder
- Tiago Reis Marques: Chief Executive Officer
About the Company
Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health. The company is led by renowned immunologists based at Stanford University and their academic research is headed by a top psychiatric academic at King’s College London. The long-term aim is to translate research into clinic-ready drugs.
Pasithea Therapeutics' secondary operations focus on establishing anti-depression clinics and mobile clinics across the US and UK, using trained pharmacists to administer intravenous infusions of ketamine. Pasithea has partnered with two successful clinics (THE IV DOC and Zen Health) for immediate exposure in locations across Los Angeles, New York City, and London.
